Atrial fibrillation and stroke prevention
GYH Lip, HS Lim - The Lancet Neurology, 2007 - thelancet.com
Atrial fibrillation (AF) is a common arrhythmia that is associated with substantial morbidity
and mortality, particularly due to stroke and thromboembolism. Anticoagulant therapy …
and mortality, particularly due to stroke and thromboembolism. Anticoagulant therapy …
Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart
HS Lim, RJ MacFadyen, GYH Lip - Archives of internal medicine, 2004 - jamanetwork.com
With diabetes mellitus reaching epidemic proportions, mainly secondary to obesity, the
impact of cardiovascular disease due to this combination makes it a dominant public health …
impact of cardiovascular disease due to this combination makes it a dominant public health …
Pulmonary artery pulsatility index: physiological basis and clinical application
HS Lim, F Gustafsson - European journal of heart failure, 2020 - Wiley Online Library
Pulmonary artery pulsatility index (PAPi) is a haemodynamic parameter that is derived from
right atrial and pulmonary artery pulse pressures. A number of reports have described the …
right atrial and pulmonary artery pulse pressures. A number of reports have described the …
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients
Cochrane, Maria Crespo Leiro, Anne Dipchand, Brian Feingold, Kathleen Grady, Edward
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention
HS Lim, AD Blann, GYH Lip - Circulation, 2004 - Am Heart Assoc
Background—High levels of the soluble fragment of CD40 ligand (sCD40L) have previously
been associated with adverse cardiovascular outcomes. CD40L–CD40 interaction has been …
been associated with adverse cardiovascular outcomes. CD40L–CD40 interaction has been …
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention
HS Lim, AD Blann, AY Chong, B Freestone… - Diabetes …, 2004 - Am Diabetes Assoc
OBJECTIVE—Vascular endothelial growth factor (VEGF) and angiopoietin (Ang)-1 and Ang-
2 are mediators of angiogenesis. More recent data suggest that the balance between these …
2 are mediators of angiogenesis. More recent data suggest that the balance between these …
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis
HS Lim, GYH Lip, AD Blann - Atherosclerosis, 2005 - Elsevier
BACKGROUND:: microvascular complications in diabetes identify those at risk of
cardiovascular disease (CVD), suggesting a link between abnormal neovascularisation and …
cardiovascular disease (CVD), suggesting a link between abnormal neovascularisation and …
The physiology of continuous-flow left ventricular assist devices
HS Lim, N Howell, A Ranasinghe - Journal of cardiac failure, 2017 - Elsevier
The use of left ventricular assist devices (LVADs) has increased significantly over the past
few years, in part because heart transplant activity has plateaued, but also because of the …
few years, in part because heart transplant activity has plateaued, but also because of the …
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes
AY Chong, B Freestone, J Patel, HS Lim… - The American journal of …, 2006 - Elsevier
Congestive heart failure (CHF) is associated with marked endothelial dysfunction. We
hypothesized that acute and chronic CHF may manifest different degrees of endothelial …
hypothesized that acute and chronic CHF may manifest different degrees of endothelial …
Real‐world evidence in a national health service: Results of the UK CardioMEMS HF system post‐market study
Abstract Aims The CardioMEMS HF System Post‐Market Study (COAST) was designed to
evaluate the safety, effectiveness, and feasibility of haemodynamic‐guided heart failure (HF) …
evaluate the safety, effectiveness, and feasibility of haemodynamic‐guided heart failure (HF) …